Online citations, reference lists, and bibliographies.
← Back to Search

Hydrogels For Peptide Hormones Delivery: Therapeutic And Tissue Engineering Applications

Mohsen Doostmohammadi, A. Ameri, R. Mohammadinejad, Negar Dehghannoudeh, I. Banat, M. Ohadi, Gholamreza Dehghannoudeh
Published 2019 · Chemistry, Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
Abstract Peptides are the most abundant biological compounds in the cells that act as enzymes, hormones, structural element, and antibodies. Mostly, peptides have problems to move across the cells because of their size and poor cellular penetration. Therefore, a carrier that could transfer peptides into cells is ideal and would be effective for disease treatment. Until now, plenty of polymers, e.g., polysaccharides, polypeptides, and lipids were used in drug delivery. Hydrogels made from polysaccharides showed significant development in targeted delivery of peptide hormones because of their natural characteristics such as networks, pore sizes, sustainability, and response to external stimuli. The main aim of the present review was therefore, to gather the important usages of the hydrogels as a carrier in peptide hormone delivery and their application in tissue engineering and regenerative medicine.
This paper references
10.15171/apb.2017.064
Cross-Linked Hydrogel for Pharmaceutical Applications: A Review
R. Parhi (2017)
10.1021/ACSAMI.6B09415
Injectable and Thermosensitive Hydrogel Containing Liraglutide as a Long-Acting Antidiabetic System.
Y. Chen (2016)
The use of polyion complex micelles to enhance the oral delivery of salmon calcitonin and transport mechanism across the intestinal epithelial barrier. Biomaterials
N Li (2012)
10.1016/J.ADDR.2007.08.019
Current challenges in non-invasive insulin delivery systems: a comparative review.
E. Khafagy (2007)
10.1517/14712598.4.8.1203
Protein and peptide parenteral controlled delivery
R. Pawar (2004)
10.1007/S13233-009-0182-0
Controlling the degradation of pH/temperature-sensitive injectable hydrogels based on poly(β-amino ester)
D. Huynh (2010)
10.1152/ajpendo.90222.2008
Exenatide can reduce glucose independent of islet hormones or gastric emptying.
V. Ionut (2008)
10.1038/nchem.2629
Materials and methods for delivery of biological drugs.
A. Zelikin (2016)
10.1210/JCEM.85.10.6881
Recombinant growth hormone (GH) therapy in GH-deficient adults: a long-term controlled study on daily versus thrice weekly injections.
G. Amato (2000)
10.1002/ADMA.200390013
Facile hydrophilic surface modification of poly(tetrafluoroethylene) using fluoroalkyl-terminated poly(ethylene glycol)s
Giyoong Tae (2003)
10.1007/978-3-319-76573-0_61-1
Synthetic Hydrogels and Their Impact on Health and Environment
Ljubiša B. Nikolić (2018)
10.1038/s41598-018-28092-8
mPEG-PLA and PLA-PEG-PLA nanoparticles as new carriers for delivery of recombinant human Growth Hormone (rhGH)
R. Ghasemi (2018)
10.1016/j.addr.2016.04.001
Lipid-based nanocarriers for oral peptide delivery.
Zhigao Niu (2016)
10.1038/srep29978
Poly(amino carbonate urethane)-based biodegradable, temperature and pH-sensitive injectable hydrogels for sustained human growth hormone delivery
V. Phan (2016)
10.1021/ACS.ENERGYFUELS.7B01691
Thermo-responsive Temporary Plugging Agent Based on Multiple Phase Transition Supramolecular Gel
Du Guangyan (2017)
10.1159/000071232
A Tripeptidyl Ensemble Perspective of Interactive Control of Growth Hormone Secretion
J. Veldhuis (2003)
10.1016/j.joms.2009.09.045
Effect of intermittent systemic administration of recombinant parathyroid hormone (1-34) on mandibular fracture healing in rats.
Henry H. Rowshan (2010)
10.1021/acsami.8b19669
Sustained Release of Exendin 4 Using Injectable and Ionic-Nano-Complex Forming Polymer Hydrogel System for Long-Term Treatment of Type 2 Diabetes Mellitus.
Bo-Bae Seo (2019)
10.1021/BM0703923
Oral bioavailability of insulin contained in polysaccharide nanoparticles.
B. Sarmento (2007)
10.1021/acsami.7b05740
Calcitonin-Loaded Thermosensitive Hydrogel for Long-Term Antiosteopenia Therapy.
Yanpeng Liu (2017)
Synthesis and characterization of novel pH-, ionic strength and temperature-sensitive hydrogel for insulin
N Rasool (2010)
10.1016/j.biomaterials.2011.03.046
Biodegradable and thermoreversible PCLA-PEG-PCLA hydrogel as a barrier for prevention of post-operative adhesion.
Z. Zhang (2011)
10.2174/0929866521666140807114240
Recent advances in protein and Peptide drug delivery: a special emphasis on polymeric nanoparticles.
Ashaben Patel (2014)
10.4103/0250-474X.42967
Protein and Peptide Drug Delivery: Oral Approaches
J. Shaji (2008)
10.1007/978-1-4613-2745-5
Recent Advances in Drug Delivery Systems
J. Anderson (1984)
10.1016/j.apsb.2014.02.005
Smart polymers for the controlled delivery of drugs – a concise overview
Honey Priya James (2014)
10.1016/j.clinthera.2012.11.004
Time-action profile of an oral enteric insulin formulation in healthy Chinese volunteers.
J. Li (2012)
10.1016/j.jsps.2014.06.004
A review on the strategies for oral delivery of proteins and peptides and their clinical perspectives
Abdul Muheem (2016)
10.1016/S0378-5173(02)00361-7
Intestinal absorption of human insulin in pigs using delivery systems based on superporous hydrogel polymers.
F. Dorkoosh (2002)
10.1080/00498250802413856
PEGylation of somatropin (recombinant human growth hormone): impact on its clearance in humans.
R. Webster (2008)
10.1007/BF00120374
Collagen and hyaluronic acid based polymeric blends as drug delivery systems for the release of physiological concentrations of growth hormone
M. Cascone (1994)
10.4269/AJTMH.2003.68.341
Fear of injections in young adults: prevalence and associations.
Yael Nir (2003)
10.1002/term.2430
Sustained release of parathyroid hormone via in situ cross‐linking gelatin hydrogels improves the therapeutic potential of tonsil‐derived mesenchymal stem cells for hypoparathyroidism
Y. S. Park (2018)
10.1016/S0169-409X(01)00239-3
Hydrogels for biomedical applications.
A. Hoffman (2002)
10.1016/S0142-9612(02)00174-6
Sustained delivery of human growth hormone from a novel gel system: SABER.
F. Okumu (2002)
10.1136/bmjgh-2018-001323
Making the case: developing innovative adherence solutions for the treatment of tuberculosis
Malvika Verma (2019)
10.1002/JPS.1113
Production of insulin-loaded poly(ethylene glycol)/poly(l-lactide) (PEG/PLA) nanoparticles by gas antisolvent techniques.
N. Elvassore (2001)
10.1016/j.biomaterials.2010.01.042
Enteric-coated capsules filled with freeze-dried chitosan/poly(gamma-glutamic acid) nanoparticles for oral insulin delivery.
K. Sonaje (2010)
University Park Press
J A Parsons (1976)
10.2174/2211738507666190321110721
Nanotechnology in insulin delivery for management of diabetes.
Fatemah Bahman (2019)
10.1016/j.jconrel.2011.08.008
Microencapsulated chitosan nanoparticles for pulmonary protein delivery: in vivo evaluation of insulin-loaded formulations.
S. Al-Qadi (2012)
10.1016/j.ijpharm.2010.03.061
Silica nanoparticle coated liposomes: a new type of hybrid nanocapsule for proteins.
Vellore J. Mohanraj (2010)
10.3390/nano9030371
Nanomaterials for Drug Delivery to the Central Nervous System
D. Teleanu (2019)
10.1016/j.bmc.2017.06.052
Therapeutic peptides: Historical perspectives, current development trends, and future directions.
Jolene L. Lau (2018)
10.1002/psc.2954
Peptide hormones and lipopeptides: from self‐assembly to therapeutic applications
J. Hutchinson (2017)
10.1016/B978-0-12-816901-8.00003-1
Fundamentals of chitosan-based hydrogels: elaboration and characterization techniques
R. A. Batista (2019)
10.1002/JPS.20566
Gastrointestinal transit and mucoadhesive characteristics of complexation hydrogels in rats.
T. Goto (2006)
10.1016/S0378-5173(99)00152-0
Instability, stabilization, and formulation of liquid protein pharmaceuticals.
W. Wang (1999)
10.1002/jbm.a.32395
Assessment of poly(methacrylic acid-co-N-vinyl pyrrolidone) as a carrier for the oral delivery of therapeutic proteins using Caco-2 and HT29-MTX cell lines.
D. A. Carr (2010)
10.1073/pnas.1509416112
Tether mutations that restore function and suppress pleiotropic phenotypes of the C. elegans isp-1(qm150) Rieske iron–sulfur protein
G. Jafari (2015)
Protein and peptide drug delivery system
D. Rao (2019)
10.1016/j.jconrel.2011.10.037
State of the art in PEGylation: the great versatility achieved after forty years of research.
G. Pasut (2012)
10.1016/j.ijpharm.2018.12.053
Enhancement of oral bioavailability of salmon calcitonin through chitosan‐modified, dual drug‐loaded nanoparticles
L. Liu (2019)
10.1016/j.biomaterials.2012.08.070
Airway delivery of peptides and proteins using nanoparticles.
C. Dombu (2013)
Temperature- and pH-Dependent Drug Release of Block Copolymers of Methacrylic Acid and Poly(Ethylene Glycol) Methyl Ether Methacrylates
Eduardo C. Atayde (2018)
10.1002/jbm.a.35742
Local delivery of parathyroid hormone-related protein-derived peptides coated onto a hydroxyapatite-based implant enhances bone regeneration in old and diabetic rats.
Juan A. Ardura (2016)
10.1016/B978-0-12-814423-7.00012-5
Preformulation Studies of Drug Substances, Protein, and Peptides: Role in Drug Discovery and Pharmaceutical Product Development
Shantanu Bandopadhyay (2018)
10.1248/CPB.49.1261
Preparation and characterization of insulin-loaded acrylic hydrogels containing absorption enhancers.
T. Uchida (2001)
10.4103/2278-344X.107844
pHEMA hydrogels: Devices for ocular drug delivery
Neha R. Tomar (2012)
10.1016/j.regpep.2003.10.028
Pharmacology of exenatide (synthetic exendin-4): a potential therapeutic for improved glycemic control of type 2 diabetes
L. L. Nielsen (2004)
Hydrogels for protein deliv
T Vermonden (2012)
Molecular design and in vitro studies of novel pH-sensitive hydrogels for the oral delivery of calcitonin. Macromolecules
M Torres-Lugo (1999)
10.1016/j.peptides.2009.10.002
Recent developments in liposomes, microparticles and nanoparticles for protein and peptide drug delivery
M. Tan (2010)
Innovative strategies for stabilization of therapeutic peptides in aqueous formulations
Christina Avanti (2012)
10.1016/j.jconrel.2014.09.031
Targeting of gastrointestinal tract for amended delivery of protein/peptide therapeutics: strategies and industrial perspectives.
V. Pawar (2014)
10.1021/ACS.BIOMAC.6B01235
Smart Polymeric Hydrogels for Cartilage Tissue Engineering: A Review on the Chemistry and Biological Functions.
Niloofar Eslahi (2016)
Isolation and characterization of exendin-4, an exendin-3 analogue, from Heloderma suspectum venom. Further evidence for an exendin receptor on dispersed acini from guinea pig pancreas.
J. Eng (1992)
10.1016/J.EJPB.2004.02.008
Investigation of the cytotoxicity and insulin transport of acrylic-based copolymer protein delivery systems in contact with Caco-2 cultures.
Aaron C Foss (2004)
10.1016/j.jconrel.2012.11.005
Polymeric hydrogels for oral insulin delivery.
K. Chaturvedi (2013)
10.1016/j.jconrel.2008.04.013
Pluronic block copolymers: evolution of drug delivery concept from inert nanocarriers to biological response modifiers.
E. Batrakova (2008)
10.4028/WWW.SCIENTIFIC.NET/MSF.940.15
Linear and Hyperbranched Copolymers of PEG-Based Acrylates and Methacrylic Acid as pH-Responsive Hydrophobic Drug Carriers
Eduardo C. Atayde Jr. (2018)
10.1016/bs.mie.2017.01.013
Nanoarmoring of Proteins by Conjugation to Block Copolymer Micelles.
Nisaraporn Suthiwangcharoen (2017)
10.1080/03639045.2017.1338723
Updates on smart polymeric carrier systems for protein delivery
Ibrahim M. El-Sherbiny (2017)
growth through the regulation of osteoblast proliferation and differentiation
HH Rowshan (2008)
10.1021/ACS.IECR.6B01573
Gas-Phase Surface Engineering of Polystyrene Beads Used to Challenge Automated Particle Inspection Systems
V. Labonté (2016)
10.2147/IJN.S83068
Value of phagocyte function screening for immunotoxicity of nanoparticles in vivo
E. Fröhlich (2015)
10.1016/B978-0-323-48104-5.00004-4
Polysaccharides in Alternative Methods for Insulin Delivery
Ana M. Morales-Burgos (2018)
10.1016/j.biotechadv.2017.05.006
Biocompatibility of hydrogel-based scaffolds for tissue engineering applications.
S. Naahidi (2017)
10.1016/j.addr.2012.01.020
Stimuli-responsive polymeric nanocarriers for the controlled transport of active compounds: concepts and applications.
E. Fleige (2012)
10.1021/bm800975j
New generation of hybrid poly/oligosaccharide nanoparticles as carriers for the nasal delivery of macromolecules.
D. Teijeiro-Osorio (2009)
10.1016/S0378-5173(02)00335-6
Preparation of poly(methacrylic acid-g-poly(ethylene glycol)) nanospheres from methacrylic monomers for pharmaceutical applications.
C. Donini (2002)
10.1248/bpb.b17-00951
Combination Strategy with Complexation Hydrogels and Cell-Penetrating Peptides for Oral Delivery of Insulin.
Yu Fukuoka (2018)
10.1152/physrev.00066.2017
The Activity of Peptides of the Calcitonin Family in Bone.
D. Naot (2019)
10.1081/LPR-120026392
Stability of Desmopressin Loaded in Liposomes
S. Law (2003)
10.1016/j.biomaterials.2013.01.013
A long-acting formulation of a polypeptide drug exenatide in treatment of diabetes using an injectable block copolymer hydrogel.
Kun Li (2013)
10.1016/S0149-7634(00)00040-3
Insulin receptors and insulin action in the brain: review and clinical implications
R. Schulingkamp (2000)
10.1021/MA050489M
Thermogelling Poly(caprolactone-b-ethylene glycol-b-caprolactone) Aqueous Solutions
S. J. Bae (2005)
10.1517/17425247.2012.735658
Liposomal delivery of proteins and peptides
Janani Swaminathan (2012)
10.1016/j.msec.2015.07.053
Classification, processing and application of hydrogels: A review.
F. Ullah (2015)
10.1089/152091502760306544
Oral insulin product hexyl-insulin monoconjugate 2 (HIM2) in type 1 diabetes mellitus: the glucose stabilization effects of HIM2.
S. Clement (2002)
10.1016/S0168-3659(02)00019-6
Elucidation of the mechanism of incorporation of insulin in controlled release systems based on complexation polymers.
M. Morishita (2002)
10.1016/j.bone.2007.11.017
Parathyroid hormone mediates bone growth through the regulation of osteoblast proliferation and differentiation.
G. Pettway (2008)
10.1016/j.biomaterials.2011.07.033
The biological efficiency and bioavailability of human growth hormone delivered using injectable, ionic, thermosensitive poly(organophosphazene)-polyethylenimine conjugate hydrogels.
Bo-Bae Seo (2011)
10.1016/j.jconrel.2008.11.014
Complexation hydrogels for intestinal delivery of interferon beta and calcitonin.
N. Kamei (2009)
Parathyroid hormone mediates
GJ Pettway
10.1016/j.jconrel.2009.11.023
Hybrid hyaluronan hydrogel encapsulating nanogel as a protein nanocarrier: new system for sustained delivery of protein with a chaperone-like function.
T. Hirakura (2010)
10.1007/978-3-319-72102-6_2
The Hypothalamic-Pituitary-Thyroid Axis: Physiological Regulation and Clinical Implications
A. Gavrila (2019)
10.1016/J.APMT.2019.04.010
Status and future scope of plant-based green hydrogels in biomedical engineering
Reza Mohammadinejad (2019)
10.1155/2016/4027542
Effects of Intermittent Administration of Parathyroid Hormone (1-34) on Bone Differentiation in Stromal Precursor Antigen-1 Positive Human Periodontal Ligament Stem Cells
X. Wang (2016)
10.1002/jps.21347
Nanoparticulate biopolymers deliver insulin orally eliciting pharmacological response.
C. Reis (2008)
DIFFERENT SUPPLEMENTS FOR FINISHING OF NELLORE CATTLE ON DEFERRED Brachiaria decumbens PASTURE DURING THE DRY SEASON
Antonio Tadeu de Andrade (2015)
10.1002/ajmg.c.31680
Growth and growth hormone in Turner syndrome: Looking back, looking ahead
E. Los (2019)
10.7326/0003-4819-87-3-387_1
Peptide hormones.
H. Tager (1974)
10.1016/j.ijpharm.2009.01.022
Evaluation of pharmacological efficacy of 'insulin-surfoplex' encapsulated polymer vesicles.
R. Rastogi (2009)
Inflammation, Hormones, and Metabolism. In: Inflammation: From Molecular and Cellular Mechanisms to the Clinic
M Khpal (2017)
10.1016/j.ejpb.2017.03.015
Novel strategies in the oral delivery of antidiabetic peptide drugs – Insulin, GLP 1 and its analogs
R. Ismail (2017)
10.4155/tde.13.104
Basics and recent advances in peptide and protein drug delivery.
Benjamin J. Bruno (2013)
10.3109/10717544.2014.940091
Stimuli-responsive hydrogels in drug delivery and tissue engineering
Nikhil Sood (2016)
10.1016/j.jconrel.2014.03.054
Controlled drug delivery systems: past forward and future back.
K. Park (2014)
10.1021/cr200157d
Hydrogels for protein delivery.
T. Vermonden (2012)
10.1002/DMRR.207
Development of oral insulin: progress and current status.
J. Still (2002)
10.1016/J.CEJ.2014.01.065
Design and applications of interpenetrating polymer network hydrogels. A review
E. Dragan (2014)
10.1021/MA990541C
Molecular design and in vitro studies of novel pH-sensitive hydrogels for the oral delivery of calcitonin
M. Torres-Lugo (1999)
10.1016/J.JCONREL.2004.03.008
Mucosal insulin delivery systems based on complexation polymer hydrogels: effect of particle size on insulin enteral absorption.
M. Morishita (2004)
10.1089/dia.2011.0050
Encapsulation of exenatide in poly-(D,L-lactide-co-glycolide) microspheres produced an investigational long-acting once-weekly formulation for type 2 diabetes.
M. DeYoung (2011)
10.1007/s11095-009-0045-6
Stability of Protein Pharmaceuticals: An Update
M. Manning (2009)
10.1517/17425247.2016.1142526
Recent advances in oral delivery of peptide hormones
Pegah Varamini (2016)
10.1016/S0939-6411(00)00090-4
Hydrogels in pharmaceutical formulations.
N. Peppas (2000)
10.2147/IJN.S63507
Developments in human growth hormone preparations: sustained-release, prolonged half-life, novel injection devices, and alternative delivery routes
Y. Cai (2014)
10.3109/10717544.2015.1019653
Archaeosomes: an excellent carrier for drug and cell delivery
G. Kaur (2016)
10.1038/nrd1695
Protein drug stability: a formulation challenge
S. Frokjaer (2005)
10.1016/S0168-3659(99)00247-3
Nanosphere based oral insulin delivery.
G. Carino (2000)
10.1016/S0031-6865(96)00049-0
Degradation pathways, analytical characterization and formulation strategies of a peptide and a protein. Calcitonine and human growth hormone in comparison.
M. Cholewinski (1996)
10.1016/j.ijpharm.2014.02.006
Pulmonary sustained release of insulin from microparticles composed of polyelectrolyte layer-by-layer assembly.
Kiran Prakash Amancha (2014)
10.1081/DDC-120037480
Effect of Poly (Ethylene Glycol) Molecular Weight and Microparticle Size on Oral Insulin Delivery from P(MAA‐g‐EG) Microparticles
Jennifer E López (2004)
10.1016/S0142-9612(02)00176-X
Photoencapsulation of osteoblasts in injectable RGD-modified PEG hydrogels for bone tissue engineering.
J. Burdick (2002)
10.1038/emboj.2009.410
Bicaudal‐D binds clathrin heavy chain to promote its transport and augments synaptic vesicle recycling
Xuan Li (2010)
10.1046/j.1464-5491.2003.01076.x
Alternative routes of insulin delivery
D. Owens (2003)
10.1002/PI.4219
pH-Responsive Hydrogels with Dispersed Hydrophobic Nanoparticles for the Delivery of Hydrophobic Therapeutic Agents.
C. Schoener (2012)
10.1016/j.jare.2013.07.006
Hydrogel: Preparation, characterization, and applications: A review
E. Ahmed (2015)
Protein/peptide drug delivery systems: practical considerations in pharmaceutical product development
PK Deb (2019)
Enteric-coated capsules filled with freeze-dried chitosan/poly (γ-glutamic acid) nanoparticles for oral insulin
K Sonaje (2010)
10.1016/S0140-6736(63)92285-2
Human growth hormone.
S. Almqvist (1963)
10.1016/j.biomaterials.2012.08.047
The use of polyion complex micelles to enhance the oral delivery of salmon calcitonin and transport mechanism across the intestinal epithelial barrier.
N. Li (2012)
10.1016/J.POLYMER.2010.02.013
Synthesis and characterization of novel pH-, ionic strength and temperature- sensitive hydrogel for insulin delivery
Nadia Rasool (2010)



This paper is referenced by
Semantic Scholar Logo Some data provided by SemanticScholar